Oleg Shikhman

Role: Gynion
Location: Miami-Fort Lauderdale, FL, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Oleg Shikhman

Serial MedTech entrepreneur with a track record of successful exits and over 30 years in…

Experience

Gynion
Present

Skills

Product Development
Operational Excellence
Leadership
Process Improvement
Marketing
P&L Management
Medical Devices
Clinical Research
Global Management
Marketing Strategy
Supply Chain Management
Life Sciences
Start-Ups
Strategy
Global Business Development
Surgical Instruments
Engineering
Gmp
Injection Molding
Iso
Mergers & Acquisitions
Design for Manufacturing
Disposables
Medicine
Lifesciences
Operating Room
V&V
Patents
Sales Operations
Vascular
Clinical Trials
Interventional Cardiology
Spine
Operations Management
Cardiology
Quality Management
Sales Process
Business Strategy
Business Development
Fmea

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@gynion.com
Personal email
•••••@•••••.com
Direct dial
+13•••••••46

Unlock verified contacts

Free to start · No credit card required

Current company

Gynion

Medical Device · 2 employees · Founded 2019 · Trumbull, Connecticut, United States

Gynion is a Women’s Health startup with a mission to offer millions of women worldwide safe, effective, and affordable in-office therapies for common gynecological conditions that improve and save lives. Gynion is developing ablative gels for multiple indications in Women’s Health addressing unmet needs in several markets with a combined value of $69 Billion. Our therapeutic platform presents an opportunity to commercialize several products with an immediate focus on Clarablex for the treatment of cervical intraepithelial neoplasia (CIN) to prevent cervical cancer and Menorrx therapy for Heavy Menstrual Bleeding (HMB) to alleviate iron-deficiency anemia. Our future product Senoblex will offer an early treatment and prevention of breast cancer. ClarablexTM is a topical gel for multiple indications in gynecology, including the treatment of cervical intraepithelial neoplasia (CIN) to prevent cervical cancer and other diseases caused by human papillomavirus (HPV). It is a simple and non-invasive treatment ready for immediate use by any healthcare provider trained in cervical cancer screening as soon as the woman is diagnosed with CIN. The low cost of Clarablex will permit all screening facilities, including those in low- and middle-income countries, to keep it in the inventory removing all barriers to healthcare access and allowing more women to receive timely treatment preventing cervical cancer. MenorrxTM is a therapy for Heavy Menstrual Bleeding (HMB). It is simpler, easier to use, and will cost significantly less than the alternatives. Because of the high cost and clinical limitations of the available options, millions of women receive no treatment or are compelled to undergo a hysterectomy. Menorrx presents a substantial opportunity to change that both in developed markets and low-resource countries.

gynion.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.